Fixed Monthly versus Less Frequent Ranibizumab Dosing and Predictors of Visual Response in Exudative Age-Related Macular Degeneration

Purpose. To examine temporal patterns of visual acuity (VA) response to pooled 0.3 mg/0.5 mg ranibizumab treatment in patients with age-related macular degeneration and identify potential baseline predictors of response. Design. Retrospective analysis. Methods. Results from 1824 ranibizumab-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariprasad, Seenu M., Morse, Lawrence S., Shapiro, Howard, Wong, Pamela, Tuomi, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515919/
https://www.ncbi.nlm.nih.gov/pubmed/23251787
http://dx.doi.org/10.1155/2012/690641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515919/
https://www.ncbi.nlm.nih.gov/pubmed/23251787
http://dx.doi.org/10.1155/2012/690641

Ejemplares similares